Period of time： 2014年1期
Publisher： Informa Healthcare
Founded in： 1996
Total resources： 42
ISSN： 1472-8214
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Emerging Drugs,volume 8,issue 1
Menu
The cyclooxygenase-2 pathway as a target for treatment or prevention of cancer
By Crosby Colin G,DuBois Raymond N in (2003)
Expert Opinion on Emerging Drugs,volume 8,issue 1 , Vol. 8, Iss. 1, 2003-05 , pp.
Access to resources
Recommend
Developments in hepatitis C therapy during 2000 – 2002
By Poordad F Fred,Tran Tram,Martin Paul in (2003)
Expert Opinion on Emerging Drugs,volume 8,issue 1 , Vol. 8, Iss. 1, 2003-05 , pp.By Ada Gordon,Ramshaw Ian in (2003)
Expert Opinion on Emerging Drugs,volume 8,issue 1 , Vol. 8, Iss. 1, 2003-05 , pp.Progress in the development of an HIV vaccine
By Tramont Edmund C,Johnston Margaret I in (2003)
Expert Opinion on Emerging Drugs,volume 8,issue 1 , Vol. 8, Iss. 1, 2003-05 , pp.By Kovarik John M,Burtin Pascale in (2003)
Expert Opinion on Emerging Drugs,volume 8,issue 1 , Vol. 8, Iss. 1, 2003-05 , pp.Emerging treatments forallergic rhinitis
Expert Opinion on Emerging Drugs,volume 8,issue 1 , Vol. 8, Iss. 1, 2003-05 , pp.Emerging treatments for asthma
By Blease Kate,Lewis Alan,Raymon Heather K in (2003)
Expert Opinion on Emerging Drugs,volume 8,issue 1 , Vol. 8, Iss. 1, 2003-05 , pp.Targeting the issues in chronic obstructive lung disease
Expert Opinion on Emerging Drugs,volume 8,issue 1 , Vol. 8, Iss. 1, 2003-05 , pp.ADP receptor antagonists as antiplatelet therapeutics
Expert Opinion on Emerging Drugs,volume 8,issue 1 , Vol. 8, Iss. 1, 2003-05 , pp.By Beresford Isabel JM,Parsons Andrew A,Hunter A Jacqueline in (2003)
Expert Opinion on Emerging Drugs,volume 8,issue 1 , Vol. 8, Iss. 1, 2003-05 , pp.
Previous
Next